Archive for the ‘int j clin exp path’ Category
According to the notice, a “knowledgeable informant” told the journal about the overlap and “fraudulent” aspects of the paper, which the editors were able to confirm. The journal retracted the paper last month.
When our co-founders launched the site in 2010, they wondered whether there would be enough retractions to write about on a regular basis. Five+ years and three full-time staffers later, and we simply don’t have the time to cover everything that comes across our desk.
In 2012, we covered a group of duplication retractions in a single post, simply because duplications happen so frequently (sadly) and often don’t tell an interesting story. So in the interest of bookkeeping, we’re picking up the practice again.
Here are five unrelated retractions for your perusal: all addressing duplications, in which the same – or mostly the same – authors published the same – or mostly the same – information in two different – or sometimes the same – journals.
So, on the buffet table we offer the following entrees: Read the rest of this entry »
A group of cancer researchers in China has lost their 2013 paper in the International Journal of Clinical and Experimental Pathology after someone tipped off the journal that the data were copied.
The article, “Importance of spondin 1 and cellular retinoic acid binding protein 1 in the clinical diagnosis of ovarian cancer,” came from Ting-Ting Jiao, Ye-Min Zhang, Lin Yao, Yuan Gao, Jian Sun, Dong-Fang Zou, Guo-Ping Wu, Dan Wang, Jun Ou, Ning Hui, who work at various Shanghai hospitals.